| Filed On | Filing |
|---|---|
| 12 Nov 2026 | 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation |
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition
Third quarter net sales of $2.063 billion increased 3.1% on a reported basis and 3.7% on a constant currency1 basis |
| 08 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
Brian Hatcher promoted to President, Recon, S.E.T., CMFT, Neuro and Biosurgery |
| 05 Aug 2026 |
8-K: Other Events
Zimmer Biomet Holdings, Inc. (“we,” “us,” “our,” the “Company” and other similar words) is filing this Exhibit 99.1 to its Current Report on Form 8-K (including this Exhibit 99.1, the “Form 8-K”) solely to recast certain financial inform... |
| 05 Aug 2026 |
8-K: Results of Operations and Financial Condition
Second quarter net sales of $2.177 billion increased 4.8% on a reported basis, 4.7% on a constant currency1 basis and 4.0% on an organic constant currency1 basis |
| 29 Jun 2026 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
RBC Capital Markets is a brand name for the capital markets businesses of Royal Bank of Canada and its affiliates. |
| 27 May 2026 |
8-K: Submission of Matters to a Vote of Security Holders
Zimmer Biomet Holdings, Inc. (the “Company”) held its annual meeting of shareholders on May 22, 2026. Shareholders took the following actions: |
| 12 May 2026 |
8-K: Regulation FD Disclosure
(WARSAW, Ind.) May 12, 2026 — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it now anticipates repurchasing up to $1 billion of its common stock during fiscal year 2026, a $250... |
| 28 Apr 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
(WARSAW, Ind.) April 28, 2026 — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced Suketu Upadhyay, Chief Financial Officer and Executive Vice President, Finance, Operations and Supply C... |
| 28 Apr 2026 |
8-K: Results of Operations and Financial Condition
First quarter net sales of $2.087 billion increased 9.3% on a reported basis, 6.8% on a constant currency1 basis and 2.9% on an organic constant currency1 basis |
| 10 Feb 2026 |
8-K: Results of Operations and Financial Condition
Fourth quarter net sales of $2.244 billion increased 10.9% on a reported basis, 9.2% on a constant currency1 basis and 5.4% on an organic constant currency1 basis |
| 12 Jan 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;Compensatory Arrangements of Certain Officers. |
| 05 Nov 2025 |
8-K: Results of Operations and Financial Condition
Third quarter net sales of $2.001 billion increased 9.7% on a reported basis, 8.6% on a constant currency1 basis and 5.0% on an organic constant currency1 basis |
| 07 Oct 2025 |
8-K: Other Events
Transaction creates the broadest, most flexible portfolio of orthopedic robotics and |
| 04 Sep 2025 |
8-K: Other Events
On September 4, 2025, Zimmer Biomet Holdings, Inc. (the “Company”) issued two new series of senior unsecured debt securities denominated in Swiss francs, comprising CHF 210,000,000 aggregate principal amount of the Company’s 0.930% Bonds... |
| 07 Aug 2025 |
8-K: Results of Operations and Financial Condition
Second quarter net sales of $2.077 billion increased 7.0% on a reported basis, 5.4% on a constant currency1 basis and 2.8% on an organic constant currency1 basis |
| 14 Jul 2025 |
8-K: Regulation FD Disclosure; Other Events
Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics |
| 30 Jun 2025 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
RBC Capital Markets is a brand name for the capital markets businesses of Royal Bank of Canada and its affiliates. |
| 03 Jun 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
Establishment of Plan; Merger of Prior Plans. The Zimmer Holdings, Inc. 2009 Stock Incentive Plan (now known as the Zimmer Biomet Holdings, Inc. 2009 Stock Incentive Plan) (the “Plan”) originally became effective on May 4, 2009 (the “200... |
| 27 May 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
This Employee Non-Disclosure, Trade Secret and Intellectual Property Agreement (“Agreement”) is made and entered into by and between Zimmer Biomet Holdings, Inc., a corporation having its principal headquarters in Warsaw, Indiana, and Ke... |
Loading...